Antivenom Efficacy in Neutralizing Histopathological Complications Following Latrodectus dahli Envenomation

  • Elham Valikhanfard-Zanjani Mail Department of Biology, Faculty of Sciences, Kharazmi University, Tehran, Iran
  • Abbas Zare-Mirakabadi Department of Venomous Animals and Antivenom Production, Razi Vaccine and Serum Research Institute, Karaj, Iran
  • Ehsan Zayerzadeh Department of Biology, Faculty of Food Industry and Agriculture, Standard Research Institute, Karaj, Iran
Latrodectus, Antivenom, Histopathological complication


Background: Nowadays use of specific antivenin for latrodectism is considered as the most effective treatment in the world. This study was undertaken to investigate the efficacy of specific antivenom against histopathological complications caused by Latrodectus dahli venom on liver, heart and kidneys tissues within 72 h.Methods: Two groups were selected, each one contained 6 male New Zealand rabbits weighing 2±0.5 kg. The ani­mals were anesthetized with 0.5 ml ketamine and 0.5 ml xylazine by intramuscular route. The L. dahli venom (0.5 mg/kg) was injected subcutaneously to both the groups. The second group of rabbits 24 h after the venom injection received specific antivenom by intravenous route. Seventy-two hours after the venom and antivenom injections, the rabbits were dissected to obtain heart, liver and kidney tissues. The tissues were stained by hematoxylin and eosin stains and histopathological studies were examined by optical microscope.Results: In group one, the venom induced myocytolysis, myocarditis, coagulation necrosis in the heart tissue and the liver tissue showed central vein congestion, congested vessels, dilated sinusoids and inflammation. However, no significant histopathological complications were observed in kidney tissues. In the second group, antivenom injec­tion greatly prevented escalation of the complications on foresaid tissues.Conclusion: Latrodectus dahli venom induces histopathological complications on vital organs. Specific antivenom injection, 24 h after the venom injection, could protect the tissues from incidence and intensification of histopatho­logical complications. Future studies in human beings should be conducted to assess the protection against the spe­cific-Latrodectus antivenin.


Afshari R, Khadem-Rezaiyan M, Balali-Mood M (2009) Spider bite (latrodectism) in Mashhad, Iran. Hum Exp Toxicol. 28:697–702.

Ahmed KZ, Bushra R (2008) Antivenin therapy of spider bite envenomation. Pak J Pharmacol. 25(2): 39–45.

Akyildiz1 B, Kurtoglu S, Poyrazoglu H, Özcan A (2009) Spider Poisoning: A report of Six Cases from the Central Anatolian Region, Turkey. Turkish J Pediatr. 51:598–604.

Allen RC, Norris RL (1991) Delayed use of antivenin in black widow spider (Latrodectus mactans) envenomation. J Wilderness Med. 2: 187–192.

Ariel F, Martinez G, Muenke M, Burgos MA (2010) From the Black Widow Spider to Human Behavior: Latrophilins, a Relatively Unknown Class of G-Pro- tein-Coupled Receptors, Are Implicat- ed in Psychiatric Disorders. Am J Med Genet. 156: 1–10.

Brown SG, Isbister GK, Stokes B (2007) Route of administration of redback spi- der bite antivenom: determining clini- cian beliefs to facilitate Bayesian anal- ysis of a clinical trial. Emerg Med Aus- tralas. 19: 458–463.

Clark RF, Wethern-Kestner S, Vance MV, Gerkin R (1992) Clinical presentation and treatment of black widow spider envenomation: a review of 163 cases. Ann Emerg Med. 21: 782–787.

Garb JE, Gonzalez A, Gillespie RG (2004) The black widow spider genus Latrodec- tus (Araneae:Theridiidae): phylogeny, biogeography, and invasion history. Mol Phylogenet Evol. 31: 1127–1142

Henkel AW, Sankaranarayanan S (1999) Mech- anisms of α-latrotoxin action. Cell Tis- sue Res. 296: 229–233.

Herberth G, Stein A, Glienke J, Taudien S, Klaman I, Herr A, Thierauch KH, Som- mer A (2005) Human Latrophilin-2 is expressed in the cytotrophoblast and syncytiotrophoblast of placenta and in endothelial cells. Am J Biochem Bio- technol. 3: 135–144.

Isbister GK (2002) Failure of intramuscular antivenom in redback spider enven- omation. Emerg Med Australas. 14:436–439.

Malley GF, Dart RC, Kuffner EF (1999) Successful treatment of latrodectism with antivenin after 90 hours. N Engl J Med. 340(8): 649–657.

Maretic Z (1983) Latrodectism: Variations in clinical manifestations provoked by Latrodectus species of spiders. Toxi- con. 21: 457–466.

Maretic Z, Stani M (1954) The health prob- lem of arachnidism. Bull Org mond Sante. 11: 1007–1022.

Maretic Z (1953) Arachnidism treated with cortisone. Report of a case. J Am Med Assoc. 152(7): 609-609.

Marzan B (1955) Pathologic reactions asso- ciated with bite of Latrodectus tredec- imguttatus. Observations in experi- mental animals. Arch Pathol Lab Med.59: 727–728.

Mirshamsi kakhaki O (2005) New records of three Latrodectus species found in Khorasan province (Araneae: Theridi- idae). Iran J Anim Biosys. 1(1): 52–58.

Nelson L, Lewin N, Howland MA (2011) Goldfrank's Toxicologic Emergencies.

th ed. McGraw-Hill Press, New York. Nentwig W, Nentwig LK (2013) Main Components of Spider Venoms. In: Nentwig W (Ed) Spider Ecophysiol-ogy, Springer, Berlin, pp. 191–202. Opie LH, Walpota B, Barsacchi R (1985) Calcium and catecholamines; rele- vance to Cardiomyopathies and sig- nificance in therapeutic strategies. J Mol Cell Cardiol. 17: 21–34.

Opie LH (1975) Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Am J Car- diol. 36: 938–953.

Prior A, Park D (2004) The toxicology of Latrodectus tredecimguttatus: the Med- iterranean black widow spider. Home- opathy. 93: 27–33.

Pulignano G, Del Sindaco D, Giovannini M, Zeisa P, Faia M, Soccorsi M, Minardi G. G Ital Cardiol (1998) Myocardialdamage after spider bite (Latrodectus tredecimguttatus) in a 16-year-old pa- tient. G Ital Cardiol. 28(10): 1149–1153.

Rafinejad J, Tirgari S, Biglarian F, Shem- shad KH (2007) Systematics, bioecol-ogy, and medical importance of widow spiders (Lathrodectus spp.) in Khora- san Province, Iran. Iran J Arthropod- Borne Dis. 1(1): 52–57.

Rajabi M (2014) delayed effects of anti- venom in cardiovascular symptoms neu- tralization causing in male dutch rab- bits. M.S.c thesis, Kharazmi Univer- sity, Tehran, Iran.

Rey G, Isbister K, Fan HW (2011) Spider bite. Lancet. 378: 2039–2047.

Shahi M, Hosseini A, Shemshad Kh, Raf- inejad J (2011) The occurrence of red- back spider Latrodectus hasselti (Arane- ae: Theridiidae) in Bandar Abbas, south- ern port of Iran. Iran J Arthropod- Borne Dis. 5: 63–68.

Silva P, Ushkaryov A (2010) The latrophil- ins, “split-personality” receptors. Adv Exp Med Biol. 706: 59–75.

Sitprija V, Sitprija S (2012) Renal effectsand injury induced by animal toxins. Toxicon. 60: 943–953.

Ushkaryov A, Rohou A, Sugita S (2008) α- Latrotoxin and its receptors. Handb Exp Pharmacol. 184: 71–206.

Valikhanfard Zanjani E, Zare Mirakabadi A, Oryan Sh, Goodarzi HR, Rajabi M (2014) Specific antivenom ability in neutralizing hepatic and renal changes

hours after Latrodectus dahli en- venomation. Iran J Arthropod-Borne Dis. 10(2): 238–245.

Van der Heyden MA, Wijnhoven TJ, Opthof T (2005) Molecular aspects of adren- ergic modulation of cardiac L-type Ca2+ channels. Cardiovasc Res. 65(1): 28–39.

Vetter RS, Isbister GK (2007) Medical as- pects of spider bites. Annu Rev Ento- mol. 53: 409–429.

White J, Cardosa JL, Fan HW (1993) Clini- cal Toxicology of Spider Bites. In: Meier J, White J (Ed) Handbook of Clinical Toxicology of Animal Ven- oms and Poisons. CRC press, United States, pp. 261–329.

How to Cite
Valikhanfard-Zanjani E, Zare-Mirakabadi A, Zayerzadeh E. Antivenom Efficacy in Neutralizing Histopathological Complications Following Latrodectus dahli Envenomation. J Arthropod Borne Dis. 11(1):42-49.
Original Article